Manufacturing News of Note—Olon starts new facility; Hikma signs on with Civic Rx

stocks
(Pixabay)

> Italy-based CDMO Olon has started construction of new manufacturing facility at its microbial CDMO facility located in Capua, Italy. Release

> Hikma Pharmaceuticals has become the latest CDMO to sign a deal with Civica Rx, the hospital-controlled company that is helping healthcare providers get drugs that are often in short supply. Release

> WuXi STA says its Analytical Service Unit in Shanghai and active pharmaceutical ingredient process R&D and manufacturing facility in Changzhou both successfully passed two inspections from the U.S. FDA. Release

> The CPhI and P-MEC China trade show in China saw record numbers, reflecting the surge of interest in manufacturing products in that country. Release 

 

 

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

CureVac has tapped Wacker to help produce 100 million doses of its mRNA-based COVID-19 vaccine at its Amsterdam facility.